526 related articles for article (PubMed ID: 15309011)
1. Is angiotensin-converting enzyme inhibitor useful in a Japanese population for secondary prevention after acute myocardial infarction? A final report of the Japanese Acute Myocardial Infarction Prospective (JAMP) study.
Ueshima K; Fukami K; Hiramori K; Hosoda S; Kishida H; Kato K; Fujita T; Tsutani K; Sakuma A;
Am Heart J; 2004 Aug; 148(2):e8. PubMed ID: 15309011
[TBL] [Abstract][Full Text] [Related]
2. [Rationale, characteristics and study design of PREAMI (Perindopril and Remodelling in the Elderly with Acute Myocardial Infraction)].
Magrini G; Nicolosi GL; Chiariello M; Ferrari R; Remme P; Tavazzi L
Ital Heart J; 2005 Nov; 6 Suppl 7():14S-23S. PubMed ID: 16485513
[TBL] [Abstract][Full Text] [Related]
3. Extended follow-up of patients randomly assigned in the Angiotensin-converting enzyme inhibition Post-Revascularization Study (APRES).
Kjøller-Hansen L; Steffensen R; Grande P
Am Heart J; 2004 Sep; 148(3):475-80. PubMed ID: 15389235
[TBL] [Abstract][Full Text] [Related]
4. Invasive vs non-invasive treatment in acute coronary syndromes and prior bypass surgery.
Gurfinkel EP; Perez de la Hoz R; Brito VM; Duronto E; Dabbous OH; Gore JM; Anderson FA;
Int J Cardiol; 2007 Jun; 119(1):65-72. PubMed ID: 17045681
[TBL] [Abstract][Full Text] [Related]
5. [Management of acute myocardial infarction in the experience of a community hospital. A prospective study].
Tincani E; Mazzoli V; Bondi M
Minerva Cardioangiol; 1997; 45(7-8):335-47. PubMed ID: 9463169
[TBL] [Abstract][Full Text] [Related]
6. A large-scale prospective cohort study on the current status of therapeutic modalities for acute myocardial infarction in Japan: rationale and initial results of the HIJAMI Registry.
Kasanuki H; Honda T; Haze K; Sumiyoshi T; Horie T; Yagi M; Yamaguchi J; Ishii Y; Fujii SY; Nagashima M; Okada H; Koganei H; Koyanagi R; Tsurumi Y; Kimura H; Ogawa H;
Am Heart J; 2005 Sep; 150(3):411-8. PubMed ID: 16169317
[TBL] [Abstract][Full Text] [Related]
7. The effect of valsartan, captopril, or both on atherosclerotic events after acute myocardial infarction: an analysis of the Valsartan in Acute Myocardial Infarction Trial (VALIANT).
McMurray J; Solomon S; Pieper K; Reed S; Rouleau J; Velazquez E; White H; Howlett J; Swedberg K; Maggioni A; Køber L; Van de Werf F; Califf R; Pfeffer M
J Am Coll Cardiol; 2006 Feb; 47(4):726-33. PubMed ID: 16487836
[TBL] [Abstract][Full Text] [Related]
8. Dual renin angiotensin system blockade in patients with acute myocardial infarction and preserved left ventricular systolic function.
Suşan M; Petrescu L; Riviş AI; Suşan RM; Burghină D; Dan R; Cozma D; Drăgulescu SI
Rom J Intern Med; 2005; 43(3-4):187-98. PubMed ID: 16812979
[TBL] [Abstract][Full Text] [Related]
9. Too little aspirin for secondary prevention after acute myocardial infarction in patients at high risk for cardiovascular events: Results from the MITRA study.
Frilling B; Schiele R; Gitt AK; Zahn R; Schneider S; Glunz HG; Gieseler U; Jagodzinski E; Senges J;
Am Heart J; 2004 Aug; 148(2):306-11. PubMed ID: 15309001
[TBL] [Abstract][Full Text] [Related]
10. Effect of Angiotensin-converting enzyme inhibition on one-year mortality and frequency of repeat acute myocardial infarction in patients with acute myocardial infarction.
Milonas C; Jernberg T; Lindbäck J; Agewall S; Wallentin L; Stenestrand U;
Am J Cardiol; 2010 May; 105(9):1229-34. PubMed ID: 20403471
[TBL] [Abstract][Full Text] [Related]
11. Suboptimal use of evidence-based medical therapy in patients with acute myocardial infarction from the Korea Acute Myocardial Infarction Registry: prescription rate, predictors, and prognostic value.
Lee JH; Yang DH; Park HS; Cho Y; Jeong MH; Kim YJ; Kim KS; Hur SH; Seong IW; Hong TJ; Cho MC; Kim CJ; Jun JE; Park WH; Chae SC;
Am Heart J; 2010 Jun; 159(6):1012-9. PubMed ID: 20569714
[TBL] [Abstract][Full Text] [Related]
12. Antecedent hypertension and the effect of captopril on the risk of adverse cardiovascular outcomes after acute myocardial infarction with left ventricular systolic dysfunction: Insights from the Survival and Ventricular Enlargement Trial.
Kenchaiah S; Davis BR; Braunwald E; Rouleau JL; Dagenais GR; Sussex B; Steingart RM; Brown EJ; Lamas GA; Gordon D; Bernstein V; Pfeffer MA;
Am Heart J; 2004 Aug; 148(2):356-64. PubMed ID: 15309009
[TBL] [Abstract][Full Text] [Related]
13. Effect of angiotensin-converting enzyme inhibitors on the power spectrum of heart rate variability in post-myocardial infarction patients.
Kontopoulos AG; Athyros VG; Papageorgiou AA; Skeberis VM; Basayiannis EC; Boudoulas H
Coron Artery Dis; 1997; 8(8-9):517-24. PubMed ID: 9431480
[TBL] [Abstract][Full Text] [Related]
14. Outcomes associated with the use of secondary prevention medications after coronary artery bypass graft surgery.
Goyal A; Alexander JH; Hafley GE; Graham SH; Mehta RH; Mack MJ; Wolf RK; Cohn LH; Kouchoukos NT; Harrington RA; Gennevois D; Gibson CM; Califf RM; Ferguson TB; Peterson ED;
Ann Thorac Surg; 2007 Mar; 83(3):993-1001. PubMed ID: 17307447
[TBL] [Abstract][Full Text] [Related]
15. [Identification of patients with acute myocardial infarction that may be discharged early: prospective evaluation with simple clinical and instrumental indicators].
Murena E; Molero U; Moio N; Pisani A; Stingone MA; Guardascione A; Grassia V; Scilla C; Marino A; Sibilio G
Ital Heart J Suppl; 2001 Jul; 2(7):775-82. PubMed ID: 11508296
[TBL] [Abstract][Full Text] [Related]
16. Comparison of treatment and outcomes for patients with acute myocardial infarction in Minneapolis/St. Paul, Minnesota, and Göteborg, Sweden.
Herlitz J; McGovern P; Dellborg M; Karlsson T; Duval S; Karlson BW; Lee S; Luepker RV
Am Heart J; 2003 Dec; 146(6):1023-9. PubMed ID: 14660994
[TBL] [Abstract][Full Text] [Related]
17. Long-term effects of quinapril with high affinity for tissue angiotensin-converting enzyme after coronary intervention in Japanese.
Otsuka M; Yamamoto H; Okimoto T; Dohi Y; Mito S; Gomyo Y; Fujii T; Matsuura W; Hirai Y; Kohno N
Am Heart J; 2004 Apr; 147(4):662-8. PubMed ID: 15077082
[TBL] [Abstract][Full Text] [Related]
18. Is ramipril really better than other angiotensin-converting enzyme inhibitors after acute myocardial infarction?
Tu K; Gunraj N; Mamdani M
Am J Cardiol; 2006 Jul; 98(1):6-9. PubMed ID: 16784910
[TBL] [Abstract][Full Text] [Related]
19. [ACE inhibitors and angiotensin II receptor antagonists in acute coronary syndrome].
Milicić D
Acta Med Croatica; 2004; 58(2):129-34. PubMed ID: 15208798
[TBL] [Abstract][Full Text] [Related]
20. Renin-angiotensin-aldosterone system polymorphisms: a role or a hole in occurrence and long-term prognosis of acute myocardial infarction at young age.
Franco E; Palumbo L; Crobu F; Anselmino M; Frea S; Matullo G; Piazza A; Trevi GP; Bergerone S
BMC Med Genet; 2007 May; 8():27. PubMed ID: 17519002
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
